Antibodies to aripiprazole and use thereof
US10816561B2 · kind B2 · utility
0Cited by
34References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2019 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Jan 7, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.